Andere Sprachen NovoCure Limited

Aktien

A140ML

JE00BYSS4X48

NVCR

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 19.04.2024			% 5 Tage	% 1. Jan.
12.09 ^USD	+0.33%		-10.91%	-19.02%

10.04.	NOVOCURE LIMITED : Piper Sandler bleibt bei seiner Kaufempfehlung	ZM
05.04.	NovoCure sagt, dass neue Daten die potenzielle therapeutische Wirkung von TTFields bei Bauchspeicheldrüsenkrebs zeigen	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research Annual Meeting 2024	08.04.
NovoCure Says New Data Show TTFields' Potential Therapeutic Effects in Pancreatic Cancer	05.04.
Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024	05.04.
Novocure to Report First Quarter 2024 Financial Results	01.04.
L’essai clinique de phase 3 METIS a atteint son critère principal, démontrant un allongement statistiquement significatif du délai médian jusqu’à la progression intracrânienne chez les patients porteurs de métastases cérébrales consécutives...	28.03.
Novocure - METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer	28.03.
Zai Lab Partner Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases	28.03.
Zai Lab, Novocure Say TTFields Therapy Delays Intracranial Progression in Non-Small Cell Lung Cancer Brain Metastases Patients	27.03.
Sector Update: Health Care Stocks Edge Higher Pre-Bell Wednesday	27.03.
Wall Street Set to Open Higher Wednesday as Investors Eye End-of-Week Economic, Inflation Data	27.03.
Sector Update: Health Care	27.03.
NovoCure Says Trial of Therapy for Brain Metastases From Lung Cancer Met Primary Endpoint; Shares Jump Pre-Bell	27.03.
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Ahead of Fed Board Governor Waller's Speech	27.03.
Novocure's lung cancer therapy succeeds in late-stage trial	27.03.
METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer	27.03.
INNOVATE-3 Late Breaking Abstract Selected as a Best Oral Presentation at ESGO	11.03.
Novocure Q4 Net Loss Widens, Revenue Rises	22.02.
NovoCure: Q4 Earnings Snapshot	22.02.
Earnings Flash (NVCR) NOVOCURE Reports Q4 Revenue $133.8M	22.02.
Novocure Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update	22.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen NovoCure Limited

Aktien

A140ML

JE00BYSS4X48

NVCR

Andere Sprachen

Filter